Skip to main content

Advertisement

SpringerLink
Log in

Refractory Hypercalcemia in Squamous Cell Carcinoma of the Esophagus—a Case Report and Review of Literature

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005;352(4):373–9.

    Article  CAS  Google Scholar 

  2. Jacobs TP, Bilezikian JP. Clinical review: Rare causes of hypercalcemia. J Clin Endocrinol Metab. 2005;90(11):6316–22.

    Article  CAS  Google Scholar 

  3. Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality: clinical experience in 126 treated patients. Ann Intern Med. 1990;112(7):499–504.

    Article  CAS  Google Scholar 

  4. Watanabe HA, Matsushita H, Matsui H, Komatsu T, Taguchi S, Sata H, et al. Esophageal carcinoma with high serum parathyroid hormone-related protein (PTHrP) level. J Gastroenterol. 1999;34(4):510–5.

    Article  CAS  Google Scholar 

  5. Jais P, Bouizar Z, Binn M, et al. Parathyroid hormone-related protein in an esophageal squamous cell carcinoma with tumor-induced hypercalcemia. Am J Gastroenterol. 1997;92(2):343–6.

    CAS  PubMed  Google Scholar 

  6. Fernandez-Real JM, Villabona C, Soler J. Oesophageal carcinoma presenting as isolated malignant hypercalcaemia. Postgrad Med J. 1994;70(828):765–6.

    Article  CAS  Google Scholar 

  7. Donovan PJ, Achong N, Griffin K, Galligan J, Pretorius CJ, McLeod DSA. PTHrP-mediated hypercalcemia: causes and survival in 138 patients. J Clin Endocrinol Metab. 2015;100(5):2024–9.

    Article  CAS  Google Scholar 

  8. Geddes LG Jr, Dorn RA, Wadleigh RG. Hypercalcemia in patients with esophageal cancer. J Exp Clin Cancer Res. 1999;18(1):61–2.

    PubMed  Google Scholar 

  9. Tachimori Y, Watanabe H, Kato H, Yamaguchi H, Nagasaki K, Honda S, et al. Hypercalcemia in patients with esophageal carcinoma. The pathophysiologic role of parathyroid hormone-related protein. Cancer. 1991;68(12):2625–9.

    Article  CAS  Google Scholar 

  10. Skrabanek P, McPartlin J, Powell D. Tumor hypercalcemia and “ectopic hyperparathyroidism”. Medicine (Baltimore). 1980;59(4):262–82.

    Article  CAS  Google Scholar 

  11. Hutchesson AC, Bundred NJ, Ratcliffe WA. Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism. Postgrad Med J. 1995;71(831):28–31.

    Article  CAS  Google Scholar 

  12. Strewler GJ, Budayr AA, Clark OH, Nissenson RA. Production of parathyroid hormone by a malignant nonparathyroid tumor in a hypercalcemic patient. J Clin Endocrinol Metab. 1993;76(5):1373–5.

    CAS  PubMed  Google Scholar 

  13. Lee JK, Chuang MJ, Lu CC, Hao LJ, Yang CY, Han TM, et al. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population. J Endocrinol Investig. 1997;20(7):404–9.

    Article  Google Scholar 

  14. Gurney H, Grill V, Martin TJ. Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia. Lancet. 1993;341(8861):1611–3.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, 15212, USA

    Hamza Arif, Moeezullah Beg & Sohaib Zahid

  2. Department of Gastroenterology, Hepatology and Nutrition, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, 15212, USA

    Moaz Sial & Michael Babich

  3. Department of Pathology, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, 15212, USA

    Aditya Talwar

  4. Department of Hematology & Oncology, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, 15212, USA

    Antonios Christou

Authors
  1. Hamza Arif
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Moeezullah Beg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sohaib Zahid
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Moaz Sial
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aditya Talwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Antonios Christou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael Babich
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

H. Arif, M. Beg and S. Zahid reviewed the literature and drafted the manuscript. M. Sial and A. Christou were involved in the care of the patient and edited the manuscript. A. Talwar provided and described pathology reports. M. Babich edited the final manuscript. H. Arif is the article guarantor.

Corresponding author

Correspondence to Hamza Arif.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

Informed consent was verbally obtained for this case report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arif, H., Beg, M., Zahid, S. et al. Refractory Hypercalcemia in Squamous Cell Carcinoma of the Esophagus—a Case Report and Review of Literature. J Gastrointest Canc 50, 939–942 (2019). https://doi.org/10.1007/s12029-018-0124-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-018-0124-1

Keywords

Search

Navigation